Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Myeloproliferative Disorders × 90 days × Clear all

Status

Sponsor Class

OTHER 34 INDUSTRY 12 NIH 6 NETWORK 3 OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 13 Breast Neoplasms 13 Neoplasms 11 Recurrence 7 Stomach Neoplasms 5 Prostatic Neoplasms 5 Colorectal Neoplasms 5 Skin Neoplasms 4 Pancreatic Neoplasms 4 Lung Neoplasms 4 Depression 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Polycystic Ovary Syndrome 3 Pilonidal Sinus 3 Ovarian Neoplasms 3 Motor Activity 3 Head and Neck Neoplasms 3 Gastrointestinal Neoplasms 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Sleep Initiation and Maintenance Disorders 2 Sarcopenia 2 Peripheral Nervous System Diseases 2 Patient Compliance 2 Pain, Postoperative 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Lymphoma, Follicular 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05440838 2026-03-06

BioPredictor

University Hospital, Angers

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡